Market size, growth to 2033 and clinical trials, side by side.
The US is the bigger Eye Health Supplements market: $1.3 Bn against $249 Mn in 2023, about 5.2 times as large.
China grows faster: 7.7% a year, against 4.2%. The gap still grows from $1.1 Bn to $1.4 Bn by 2033.
Clinical research: 18 active trials in the US, 6 in China.
| Measure | ||
|---|---|---|
| Market size, 2023 | $1.3 Bn | $249 Mn |
| Market size, 2033 projected | $2 Bn | $523 Mn |
| Growth a year (CAGR) | 4.2% | 7.7% |
| Money added, 2023–2033 | $663 Mn | $274 Mn |
| Share of the world market | 42% | 8% |
| Size rank of 24 countries | #1 | #2 |
| Market per person, 2023 | $3.81 | $0.18 |
| Active clinical trials | 18 | 6 |
| Full report | US report | China report |
US China · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
The US is the bigger Eye Health Supplements market: $1.3 Bn against $249 Mn in 2023, about 5.2 times as large.
China grows faster: 7.7% a year, against 4.2%. The gap still grows from $1.1 Bn to $1.4 Bn by 2033.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.